In Vitro Effect of Flow Velocity on Aerodynamic Parameters of a Cromospir Metered Dose Inhaler


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The effect of changing flow velocity on the aerodynamic particle size distribution of Cromospir metered dose inhaler (MDI) was studied using an Andersen cascade impactor (ACI) in the standard configuration designed for sampling at flow velocity 28.3 L/min and in a modified configuration at 60 L/min. The aerodynamic particle size distribution and the respirable fraction of the aerosol changed if the flow velocity of air passing through the impactor changed. Studies of the aerodynamic properties of aerosols with patient inhalation modeled at various air flow rates are recommended during quality assessment method development for aerosols and for in vitro comparisons of MDI efficiencies.

About the authors

M. V. Nezdol’eva

Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation

Email: truhacheva@expmed.ru
Russian Federation, 8/2 Petrovskii Blvd., Moscow, 127051

R. R. Suleimanov

Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation

Email: truhacheva@expmed.ru
Russian Federation, 8/2 Petrovskii Blvd., Moscow, 127051

O. A. Popova

Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation

Email: truhacheva@expmed.ru
Russian Federation, 8/2 Petrovskii Blvd., Moscow, 127051

S. G. Larionova

Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation

Email: truhacheva@expmed.ru
Russian Federation, 8/2 Petrovskii Blvd., Moscow, 127051

O. A. Pobedin

Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation

Email: truhacheva@expmed.ru
Russian Federation, 8/2 Petrovskii Blvd., Moscow, 127051

L. A. Trukhacheva

Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation

Author for correspondence.
Email: truhacheva@expmed.ru
Russian Federation, 8/2 Petrovskii Blvd., Moscow, 127051


Copyright (c) 2019 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies